<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://www.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2026, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Fri, 29 May 2026 16:04:00 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://www.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>Form  SD         Sight Sciences, Inc.                 </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++SD+++++++++Sight+Sciences%2C+Inc.+++++++++++++++++/26574965.html</link>
   <description>si-local-file:///var/storage/secattach/20260529/26574965.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++SD+++++++++Sight+Sciences%2C+Inc.+++++++++++++++++/26574965.html</guid>
   <pubDate>Fri, 29 May 2026 16:04:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.46376965</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SGHT</category>
   	  </item>
  <item>
   <title>Form  SD         Sight Sciences, Inc.                 </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++SD+++++++++Sight+Sciences%2C+Inc.+++++++++++++++++/26574965.html</link>
   <description>si-local-file:///var/storage/secattach/20260529/26574965.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++SD+++++++++Sight+Sciences%2C+Inc.+++++++++++++++++/26574965.html</guid>
   <pubDate>Fri, 29 May 2026 16:04:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.46376965</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SGHT</category>
   	  </item>
  <item>
   <title>Sight Sciences Inc. (SGHT) PT Raised to $5.15 at Citi</title>
   <link>http://www.streetinsider.com/Analyst+PT+Change/Sight+Sciences+Inc.+%28SGHT%29+PT+Raised+to+%245.15+at+Citi/26560834.html</link>
   <description>Citi analyst Joanne Wuensch raised the price target on Sight Sciences Inc. (NASDAQ: SGHT) to $5.15  (from $4.35) while maintaining a Neutral rating.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Analyst+PT+Change/Sight+Sciences+Inc.+%28SGHT%29+PT+Raised+to+%245.15+at+Citi/26560834.html</guid>
   <pubDate>Thu, 28 May 2026 06:53:30 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">SGHT</category>
   	  </item>
  <item>
   <title>Form  4          Sight Sciences, Inc.      For: May 18  Filed by: Bauerlein Alison</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Sight+Sciences%2C+Inc.++++++For%3A+May+18++Filed+by%3A+Bauerlein+Alison/26522065.html</link>
   <description>si-local-file:///var/storage/secattach/20260519/26522065.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Sight+Sciences%2C+Inc.++++++For%3A+May+18++Filed+by%3A+Bauerlein+Alison/26522065.html</guid>
   <pubDate>Tue, 19 May 2026 16:42:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.46376965</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SGHT</category>
   	  </item>
  <item>
   <title>Form  4          Sight Sciences, Inc.      For: May 18  Filed by: Bauerlein Alison</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Sight+Sciences%2C+Inc.++++++For%3A+May+18++Filed+by%3A+Bauerlein+Alison/26522065.html</link>
   <description>si-local-file:///var/storage/secattach/20260519/26522065.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Sight+Sciences%2C+Inc.++++++For%3A+May+18++Filed+by%3A+Bauerlein+Alison/26522065.html</guid>
   <pubDate>Tue, 19 May 2026 16:42:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.46376965</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SGHT</category>
   	  </item>
  <item>
   <title>Form  144        Sight Sciences, Inc.                   Filed by: Bauerlein Alison</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++144++++++++Sight+Sciences%2C+Inc.+++++++++++++++++++Filed+by%3A+Bauerlein+Alison/26513372.html</link>
   <description>si-local-file:///var/storage/secattach/20260518/26513372.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++144++++++++Sight+Sciences%2C+Inc.+++++++++++++++++++Filed+by%3A+Bauerlein+Alison/26513372.html</guid>
   <pubDate>Mon, 18 May 2026 15:35:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.46376965</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SGHT</category>
   	  </item>
  <item>
   <title>Form  144        Sight Sciences, Inc.                   Filed by: Bauerlein Alison</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++144++++++++Sight+Sciences%2C+Inc.+++++++++++++++++++Filed+by%3A+Bauerlein+Alison/26513372.html</link>
   <description>si-local-file:///var/storage/secattach/20260518/26513372.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++144++++++++Sight+Sciences%2C+Inc.+++++++++++++++++++Filed+by%3A+Bauerlein+Alison/26513372.html</guid>
   <pubDate>Mon, 18 May 2026 15:35:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.46376965</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SGHT</category>
   	  </item>
  <item>
   <title>Form  10-Q       Sight Sciences, Inc.      For: Mar 31</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Sight+Sciences%2C+Inc.++++++For%3A+Mar+31/26444633.html</link>
   <description>si-local-file:///var/storage/secattach/20260506/26444633.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Sight+Sciences%2C+Inc.++++++For%3A+Mar+31/26444633.html</guid>
   <pubDate>Wed, 06 May 2026 16:31:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.46376965</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SGHT</category>
   	  </item>
  <item>
   <title>Form  10-Q       Sight Sciences, Inc.      For: Mar 31</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Sight+Sciences%2C+Inc.++++++For%3A+Mar+31/26444633.html</link>
   <description>si-local-file:///var/storage/secattach/20260506/26444633.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Sight+Sciences%2C+Inc.++++++For%3A+Mar+31/26444633.html</guid>
   <pubDate>Wed, 06 May 2026 16:31:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.46376965</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SGHT</category>
   	  </item>
  <item>
   <title>Sight Sciences, Inc. (SGHT) Misses Q1 EPS by 7c ; Offers Guidance</title>
   <link>http://www.streetinsider.com/Earnings/Sight+Sciences%2C+Inc.+%28SGHT%29+Misses+Q1+EPS+by+7c+%3B+Offers+Guidance/26444365.html</link>
   <description>&lt;p&gt;Sight Sciences, Inc. (NASDAQ: SGHT) reported Q1 EPS of ($0.24), $0.07 worse than the analyst estimate of ($0.17). Revenue for the quarter came in at $19.7 million versus the consensus estimate of $18.55 million.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;GUIDANCE:&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;Sight Sciences, Inc. sees FY2026 revenue of $83-89 million, versus the consensus of $84.56 million.&lt;/p&gt;&lt;p&gt;For earnings history and earnings-related data on Sight Sciences, Inc. (SGHT) &lt;a href=&quot;http://www.streetinsider.com/ec_earnings.php?q=SGHT&quot;&gt;click here&lt;/a&gt;.&lt;/p&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Earnings/Sight+Sciences%2C+Inc.+%28SGHT%29+Misses+Q1+EPS+by+7c+%3B+Offers+Guidance/26444365.html</guid>
   <pubDate>Wed, 06 May 2026 16:23:27 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">SGHT</category>
   	  </item>
  <item>
   <title>Sight Sciences, Inc. (SGHT) Misses Q1 EPS by 7c ; Offers Guidance</title>
   <link>http://www.streetinsider.com/Guidance/Sight+Sciences%2C+Inc.+%28SGHT%29+Misses+Q1+EPS+by+7c+%3B+Offers+Guidance/26444365.html</link>
   <description>&lt;p&gt;Sight Sciences, Inc. (NASDAQ: SGHT) reported Q1 EPS of ($0.24), $0.07 worse than the analyst estimate of ($0.17). Revenue for the quarter came in at $19.7 million versus the consensus estimate of $18.55 million.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;GUIDANCE:&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;Sight Sciences, Inc. sees FY2026 revenue of $83-89 million, versus the consensus of $84.56 million.&lt;/p&gt;&lt;p&gt;For earnings history and earnings-related data on Sight Sciences, Inc. (SGHT) &lt;a href=&quot;http://www.streetinsider.com/ec_earnings.php?q=SGHT&quot;&gt;click here&lt;/a&gt;.&lt;/p&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Guidance/Sight+Sciences%2C+Inc.+%28SGHT%29+Misses+Q1+EPS+by+7c+%3B+Offers+Guidance/26444365.html</guid>
   <pubDate>Wed, 06 May 2026 16:23:27 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">SGHT</category>
   	  </item>
  <item>
   <title>Form  8-K        Sight Sciences, Inc.      For: May 06</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Sight+Sciences%2C+Inc.++++++For%3A+May+06/26443743.html</link>
   <description>si-local-file:///var/storage/secattach/20260506/26443743.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Sight+Sciences%2C+Inc.++++++For%3A+May+06/26443743.html</guid>
   <pubDate>Wed, 06 May 2026 16:09:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.46376965</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SGHT</category>
   	  </item>
  <item>
   <title>Form  8-K        Sight Sciences, Inc.      For: May 06</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Sight+Sciences%2C+Inc.++++++For%3A+May+06/26443743.html</link>
   <description>si-local-file:///var/storage/secattach/20260506/26443743.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Sight+Sciences%2C+Inc.++++++For%3A+May+06/26443743.html</guid>
   <pubDate>Wed, 06 May 2026 16:09:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.46376965</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SGHT</category>
   	  </item>
  <item>
   <title>Sight Sciences Reports First Quarter 2026 Financial Results and Raises Full Year 2026 Revenue Guidance</title>
   <link>http://www.streetinsider.com/Press+Releases/Sight+Sciences+Reports+First+Quarter+2026+Financial+Results+and+Raises+Full+Year+2026+Revenue+Guidance/26443502.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;MENLO PARK, Calif., May  06, 2026  (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (&amp;quot;Sight Sciences&amp;quot; or the &amp;quot;Company&amp;quot;), an eyecare technology company focused on developing and commercializing innovative, interventional technologies intended to transform care and improve patients’ lives, today reported financial results for the first quarter ended March 31, 2026 and raised its revenue guidance for full year 2026.&lt;/p&gt;  &lt;p&gt;&lt;strong&gt;Recent Financial and Business Highlights&lt;/strong&gt;&lt;/p&gt;  &lt;ul type=&quot;disc&quot;&gt;&lt;li style=&quot;text-align:justify;&quot;&gt;Generated total revenue of $19.7 million in the first quarter of 2026, an increase of 13% compared to the same period in the prior year. &lt;br/&gt;&lt;br/&gt;&lt;/li&gt;&lt;li style=&quot;text-align:justify;&quot;&gt;Drove Interventional</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Sight+Sciences+Reports+First+Quarter+2026+Financial+Results+and+Raises+Full+Year+2026+Revenue+Guidance/26443502.html</guid>
   <pubDate>Wed, 06 May 2026 16:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.23222841</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50202471</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00004836</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.46376965</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52929899</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SGHT</category>
   	  </item>
  <item>
   <title>Sight Sciences Reports First Quarter 2026 Financial Results and Raises Full Year 2026 Revenue Guidance</title>
   <link>http://www.streetinsider.com/Press+Releases/Sight+Sciences+Reports+First+Quarter+2026+Financial+Results+and+Raises+Full+Year+2026+Revenue+Guidance/26443502.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;MENLO PARK, Calif., May  06, 2026  (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (&amp;quot;Sight Sciences&amp;quot; or the &amp;quot;Company&amp;quot;), an eyecare technology company focused on developing and commercializing innovative, interventional technologies intended to transform care and improve patients’ lives, today reported financial results for the first quarter ended March 31, 2026 and raised its revenue guidance for full year 2026.&lt;/p&gt;  &lt;p&gt;&lt;strong&gt;Recent Financial and Business Highlights&lt;/strong&gt;&lt;/p&gt;  &lt;ul type=&quot;disc&quot;&gt;&lt;li style=&quot;text-align:justify;&quot;&gt;Generated total revenue of $19.7 million in the first quarter of 2026, an increase of 13% compared to the same period in the prior year. &lt;br/&gt;&lt;br/&gt;&lt;/li&gt;&lt;li style=&quot;text-align:justify;&quot;&gt;Drove Interventional</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Sight+Sciences+Reports+First+Quarter+2026+Financial+Results+and+Raises+Full+Year+2026+Revenue+Guidance/26443502.html</guid>
   <pubDate>Wed, 06 May 2026 16:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.23222841</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50202471</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00004836</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.46376965</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52929899</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SGHT</category>
   	  </item>
  <item>
   <title>Sight Sciences Reports First Quarter 2026 Financial Results and Raises Full Year 2026 Revenue Guidance</title>
   <link>http://www.streetinsider.com/Press+Releases/Sight+Sciences+Reports+First+Quarter+2026+Financial+Results+and+Raises+Full+Year+2026+Revenue+Guidance/26443502.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;MENLO PARK, Calif., May  06, 2026  (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (&amp;quot;Sight Sciences&amp;quot; or the &amp;quot;Company&amp;quot;), an eyecare technology company focused on developing and commercializing innovative, interventional technologies intended to transform care and improve patients’ lives, today reported financial results for the first quarter ended March 31, 2026 and raised its revenue guidance for full year 2026.&lt;/p&gt;  &lt;p&gt;&lt;strong&gt;Recent Financial and Business Highlights&lt;/strong&gt;&lt;/p&gt;  &lt;ul type=&quot;disc&quot;&gt;&lt;li style=&quot;text-align:justify;&quot;&gt;Generated total revenue of $19.7 million in the first quarter of 2026, an increase of 13% compared to the same period in the prior year. &lt;br/&gt;&lt;br/&gt;&lt;/li&gt;&lt;li style=&quot;text-align:justify;&quot;&gt;Drove Interventional</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Sight+Sciences+Reports+First+Quarter+2026+Financial+Results+and+Raises+Full+Year+2026+Revenue+Guidance/26443502.html</guid>
   <pubDate>Wed, 06 May 2026 16:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.23222841</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50202471</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00004836</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.46376965</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52929899</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SGHT</category>
   	  </item>
  <item>
   <title>Sight Sciences Reports First Quarter 2026 Financial Results and Raises Full Year 2026 Revenue Guidance</title>
   <link>http://www.streetinsider.com/Press+Releases/Sight+Sciences+Reports+First+Quarter+2026+Financial+Results+and+Raises+Full+Year+2026+Revenue+Guidance/26443502.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;MENLO PARK, Calif., May  06, 2026  (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (&amp;quot;Sight Sciences&amp;quot; or the &amp;quot;Company&amp;quot;), an eyecare technology company focused on developing and commercializing innovative, interventional technologies intended to transform care and improve patients’ lives, today reported financial results for the first quarter ended March 31, 2026 and raised its revenue guidance for full year 2026.&lt;/p&gt;  &lt;p&gt;&lt;strong&gt;Recent Financial and Business Highlights&lt;/strong&gt;&lt;/p&gt;  &lt;ul type=&quot;disc&quot;&gt;&lt;li style=&quot;text-align:justify;&quot;&gt;Generated total revenue of $19.7 million in the first quarter of 2026, an increase of 13% compared to the same period in the prior year. &lt;br/&gt;&lt;br/&gt;&lt;/li&gt;&lt;li style=&quot;text-align:justify;&quot;&gt;Drove Interventional</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Sight+Sciences+Reports+First+Quarter+2026+Financial+Results+and+Raises+Full+Year+2026+Revenue+Guidance/26443502.html</guid>
   <pubDate>Wed, 06 May 2026 16:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.23222841</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50202471</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00004836</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.46376965</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52929899</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SGHT</category>
   	  </item>
  <item>
   <title>Sight Sciences Reports First Quarter 2026 Financial Results and Raises Full Year 2026 Revenue Guidance</title>
   <link>http://www.streetinsider.com/Press+Releases/Sight+Sciences+Reports+First+Quarter+2026+Financial+Results+and+Raises+Full+Year+2026+Revenue+Guidance/26443502.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;MENLO PARK, Calif., May  06, 2026  (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (&amp;quot;Sight Sciences&amp;quot; or the &amp;quot;Company&amp;quot;), an eyecare technology company focused on developing and commercializing innovative, interventional technologies intended to transform care and improve patients’ lives, today reported financial results for the first quarter ended March 31, 2026 and raised its revenue guidance for full year 2026.&lt;/p&gt;  &lt;p&gt;&lt;strong&gt;Recent Financial and Business Highlights&lt;/strong&gt;&lt;/p&gt;  &lt;ul type=&quot;disc&quot;&gt;&lt;li style=&quot;text-align:justify;&quot;&gt;Generated total revenue of $19.7 million in the first quarter of 2026, an increase of 13% compared to the same period in the prior year. &lt;br/&gt;&lt;br/&gt;&lt;/li&gt;&lt;li style=&quot;text-align:justify;&quot;&gt;Drove Interventional</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Sight+Sciences+Reports+First+Quarter+2026+Financial+Results+and+Raises+Full+Year+2026+Revenue+Guidance/26443502.html</guid>
   <pubDate>Wed, 06 May 2026 16:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.23222841</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50202471</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00004836</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.46376965</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52929899</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SGHT</category>
   	  </item>
  <item>
   <title>Sight Sciences Reports First Quarter 2026 Financial Results and Raises Full Year 2026 Revenue Guidance</title>
   <link>http://www.streetinsider.com/Press+Releases/Sight+Sciences+Reports+First+Quarter+2026+Financial+Results+and+Raises+Full+Year+2026+Revenue+Guidance/26443502.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;MENLO PARK, Calif., May  06, 2026  (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (&amp;quot;Sight Sciences&amp;quot; or the &amp;quot;Company&amp;quot;), an eyecare technology company focused on developing and commercializing innovative, interventional technologies intended to transform care and improve patients’ lives, today reported financial results for the first quarter ended March 31, 2026 and raised its revenue guidance for full year 2026.&lt;/p&gt;  &lt;p&gt;&lt;strong&gt;Recent Financial and Business Highlights&lt;/strong&gt;&lt;/p&gt;  &lt;ul type=&quot;disc&quot;&gt;&lt;li style=&quot;text-align:justify;&quot;&gt;Generated total revenue of $19.7 million in the first quarter of 2026, an increase of 13% compared to the same period in the prior year. &lt;br/&gt;&lt;br/&gt;&lt;/li&gt;&lt;li style=&quot;text-align:justify;&quot;&gt;Drove Interventional</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Sight+Sciences+Reports+First+Quarter+2026+Financial+Results+and+Raises+Full+Year+2026+Revenue+Guidance/26443502.html</guid>
   <pubDate>Wed, 06 May 2026 16:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.23222841</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50202471</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00004836</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.46376965</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52929899</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SGHT</category>
   	  </item>
  <item>
   <title>Sight Sciences Reports First Quarter 2026 Financial Results and Raises Full Year 2026 Revenue Guidance</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Sight+Sciences+Reports+First+Quarter+2026+Financial+Results+and+Raises+Full+Year+2026+Revenue+Guidance/26443502.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;MENLO PARK, Calif., May  06, 2026  (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (&amp;quot;Sight Sciences&amp;quot; or the &amp;quot;Company&amp;quot;), an eyecare technology company focused on developing and commercializing innovative, interventional technologies intended to transform care and improve patients’ lives, today reported financial results for the first quarter ended March 31, 2026 and raised its revenue guidance for full year 2026.&lt;/p&gt;  &lt;p&gt;&lt;strong&gt;Recent Financial and Business Highlights&lt;/strong&gt;&lt;/p&gt;  &lt;ul type=&quot;disc&quot;&gt;&lt;li style=&quot;text-align:justify;&quot;&gt;Generated total revenue of $19.7 million in the first quarter of 2026, an increase of 13% compared to the same period in the prior year. &lt;br/&gt;&lt;br/&gt;&lt;/li&gt;&lt;li style=&quot;text-align:justify;&quot;&gt;Drove Interventional</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Sight+Sciences+Reports+First+Quarter+2026+Financial+Results+and+Raises+Full+Year+2026+Revenue+Guidance/26443502.html</guid>
   <pubDate>Wed, 06 May 2026 16:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.23222841</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50202471</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00004836</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.46376965</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52929899</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SGHT</category>
   	  </item>
  <item>
   <title>Sight Sciences Reports First Quarter 2026 Financial Results and Raises Full Year 2026 Revenue Guidance</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Sight+Sciences+Reports+First+Quarter+2026+Financial+Results+and+Raises+Full+Year+2026+Revenue+Guidance/26443502.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;MENLO PARK, Calif., May  06, 2026  (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (&amp;quot;Sight Sciences&amp;quot; or the &amp;quot;Company&amp;quot;), an eyecare technology company focused on developing and commercializing innovative, interventional technologies intended to transform care and improve patients’ lives, today reported financial results for the first quarter ended March 31, 2026 and raised its revenue guidance for full year 2026.&lt;/p&gt;  &lt;p&gt;&lt;strong&gt;Recent Financial and Business Highlights&lt;/strong&gt;&lt;/p&gt;  &lt;ul type=&quot;disc&quot;&gt;&lt;li style=&quot;text-align:justify;&quot;&gt;Generated total revenue of $19.7 million in the first quarter of 2026, an increase of 13% compared to the same period in the prior year. &lt;br/&gt;&lt;br/&gt;&lt;/li&gt;&lt;li style=&quot;text-align:justify;&quot;&gt;Drove Interventional</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Sight+Sciences+Reports+First+Quarter+2026+Financial+Results+and+Raises+Full+Year+2026+Revenue+Guidance/26443502.html</guid>
   <pubDate>Wed, 06 May 2026 16:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.23222841</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50202471</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00004836</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.46376965</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52929899</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SGHT</category>
   	  </item>
  <item>
   <title>Sight Sciences Reports First Quarter 2026 Financial Results and Raises Full Year 2026 Revenue Guidance</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Sight+Sciences+Reports+First+Quarter+2026+Financial+Results+and+Raises+Full+Year+2026+Revenue+Guidance/26443502.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;MENLO PARK, Calif., May  06, 2026  (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (&amp;quot;Sight Sciences&amp;quot; or the &amp;quot;Company&amp;quot;), an eyecare technology company focused on developing and commercializing innovative, interventional technologies intended to transform care and improve patients’ lives, today reported financial results for the first quarter ended March 31, 2026 and raised its revenue guidance for full year 2026.&lt;/p&gt;  &lt;p&gt;&lt;strong&gt;Recent Financial and Business Highlights&lt;/strong&gt;&lt;/p&gt;  &lt;ul type=&quot;disc&quot;&gt;&lt;li style=&quot;text-align:justify;&quot;&gt;Generated total revenue of $19.7 million in the first quarter of 2026, an increase of 13% compared to the same period in the prior year. &lt;br/&gt;&lt;br/&gt;&lt;/li&gt;&lt;li style=&quot;text-align:justify;&quot;&gt;Drove Interventional</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Sight+Sciences+Reports+First+Quarter+2026+Financial+Results+and+Raises+Full+Year+2026+Revenue+Guidance/26443502.html</guid>
   <pubDate>Wed, 06 May 2026 16:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.23222841</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50202471</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00004836</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.46376965</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52929899</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SGHT</category>
   	  </item>
  <item>
   <title>Sight Sciences Reports First Quarter 2026 Financial Results and Raises Full Year 2026 Revenue Guidance</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Sight+Sciences+Reports+First+Quarter+2026+Financial+Results+and+Raises+Full+Year+2026+Revenue+Guidance/26443502.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;MENLO PARK, Calif., May  06, 2026  (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (&amp;quot;Sight Sciences&amp;quot; or the &amp;quot;Company&amp;quot;), an eyecare technology company focused on developing and commercializing innovative, interventional technologies intended to transform care and improve patients’ lives, today reported financial results for the first quarter ended March 31, 2026 and raised its revenue guidance for full year 2026.&lt;/p&gt;  &lt;p&gt;&lt;strong&gt;Recent Financial and Business Highlights&lt;/strong&gt;&lt;/p&gt;  &lt;ul type=&quot;disc&quot;&gt;&lt;li style=&quot;text-align:justify;&quot;&gt;Generated total revenue of $19.7 million in the first quarter of 2026, an increase of 13% compared to the same period in the prior year. &lt;br/&gt;&lt;br/&gt;&lt;/li&gt;&lt;li style=&quot;text-align:justify;&quot;&gt;Drove Interventional</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Sight+Sciences+Reports+First+Quarter+2026+Financial+Results+and+Raises+Full+Year+2026+Revenue+Guidance/26443502.html</guid>
   <pubDate>Wed, 06 May 2026 16:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.23222841</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50202471</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00004836</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.46376965</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52929899</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SGHT</category>
   	  </item>
  <item>
   <title>Sight Sciences Reports First Quarter 2026 Financial Results and Raises Full Year 2026 Revenue Guidance</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Sight+Sciences+Reports+First+Quarter+2026+Financial+Results+and+Raises+Full+Year+2026+Revenue+Guidance/26443502.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;MENLO PARK, Calif., May  06, 2026  (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (&amp;quot;Sight Sciences&amp;quot; or the &amp;quot;Company&amp;quot;), an eyecare technology company focused on developing and commercializing innovative, interventional technologies intended to transform care and improve patients’ lives, today reported financial results for the first quarter ended March 31, 2026 and raised its revenue guidance for full year 2026.&lt;/p&gt;  &lt;p&gt;&lt;strong&gt;Recent Financial and Business Highlights&lt;/strong&gt;&lt;/p&gt;  &lt;ul type=&quot;disc&quot;&gt;&lt;li style=&quot;text-align:justify;&quot;&gt;Generated total revenue of $19.7 million in the first quarter of 2026, an increase of 13% compared to the same period in the prior year. &lt;br/&gt;&lt;br/&gt;&lt;/li&gt;&lt;li style=&quot;text-align:justify;&quot;&gt;Drove Interventional</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Sight+Sciences+Reports+First+Quarter+2026+Financial+Results+and+Raises+Full+Year+2026+Revenue+Guidance/26443502.html</guid>
   <pubDate>Wed, 06 May 2026 16:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.23222841</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50202471</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00004836</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.46376965</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52929899</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SGHT</category>
   	  </item>
  <item>
   <title>Sight Sciences Reports First Quarter 2026 Financial Results and Raises Full Year 2026 Revenue Guidance</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Sight+Sciences+Reports+First+Quarter+2026+Financial+Results+and+Raises+Full+Year+2026+Revenue+Guidance/26443502.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;MENLO PARK, Calif., May  06, 2026  (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (&amp;quot;Sight Sciences&amp;quot; or the &amp;quot;Company&amp;quot;), an eyecare technology company focused on developing and commercializing innovative, interventional technologies intended to transform care and improve patients’ lives, today reported financial results for the first quarter ended March 31, 2026 and raised its revenue guidance for full year 2026.&lt;/p&gt;  &lt;p&gt;&lt;strong&gt;Recent Financial and Business Highlights&lt;/strong&gt;&lt;/p&gt;  &lt;ul type=&quot;disc&quot;&gt;&lt;li style=&quot;text-align:justify;&quot;&gt;Generated total revenue of $19.7 million in the first quarter of 2026, an increase of 13% compared to the same period in the prior year. &lt;br/&gt;&lt;br/&gt;&lt;/li&gt;&lt;li style=&quot;text-align:justify;&quot;&gt;Drove Interventional</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Sight+Sciences+Reports+First+Quarter+2026+Financial+Results+and+Raises+Full+Year+2026+Revenue+Guidance/26443502.html</guid>
   <pubDate>Wed, 06 May 2026 16:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.23222841</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50202471</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00004836</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.46376965</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52929899</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SGHT</category>
   	  </item>
 </channel>
</rss>
